Pharmabiz51m
Centre bans chloramphenicol and nitrofurans for use in food-producing animals
The Union health ministry has banned the import, manufacture, sale and distribution of antibiotic chloramphenicol and nitrofurans class of drugs for use in any food-producing animal rearing system ...
Pharmabiz1h
Centre reconstitutes DTAB
The new notification, issued on March 12 reconstitutes the 18 member committee which was constituted on October 18, 2021. The DTAB was reconstituted in May, 2018, prior to that. The revised board will ...
Pharmabiz1h
Focus on futuristic products, affordable solutions, says DoP secretary
Focus on futuristic products, affordable solutions, says DoP secretary: Our Bureau, New Delhi Thursday, March 13, 2025, 18:30 Hrs [IST] Focus on developing futuristic products and ...
Pharmabiz2h
Corona Remedies introduces affordable generic version of empagliflozin for type 2 diabetes
Corona Remedies introduces affordable generic version of empagliflozin for type 2 diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:50 Hrs [IST] Corona Remedies Limited ha ...
Pharmabiz2h
Wockhardt Hospitals, Mira Road successfully performs first Swap Kidney Transplant
Wockhardt Hospitals, Mira Road successfully performs first Swap Kidney Transplant: Our Bureau, Mumbai Thursday, March 13, 2025, 17:40 Hrs [IST] In a significant development that c ...
Pharmabiz2h
Harbour BioMed launches Élancé Therapeutics to advance next-generation obesity therapies
Harbour BioMed launches Élancé Therapeutics to advance next-generation obesity therapies: Cambridge, Massachusetts Thursday, March 13, 2025, 18:00 Hrs [IST] Harbour BioMed, a gl ...
Pharmabiz2h
Mankind Pharma launches affordable empagliflozin in India for diabetes
Mankind Pharma launches affordable empagliflozin in India for diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:30 Hrs [IST] Mankind Pharma has launched its affordable gen ...
Pharmabiz3h
PolyPid completes enrollment in phase 3 SHIELD II trial of D-PLEX100 for prevention of abdominal colorectal surgical site infections
PolyPid completes enrollment in phase 3 SHIELD II trial of D-PLEX100 for prevention of abdominal colorectal surgical site infections: Petach Tikva, Israel Thursday, March 13, 2025 ...
Pharmabiz4h
Lipocine announces US FDA labelling changes for testosterone products
Lipocine announces US FDA labelling changes for testosterone products: Salt Lake City Thursday, March 13, 2025, 16:00 Hrs [IST] Lipocine Inc., a biopharmaceutical company leveragi ...
Pharmabiz5h
QurAlis announces positive data from phase 1 trial of QRL-101 evaluating biomarkers of ALS and epilepsy in healthy volunteers
QRL-101-03 (NCT06532396) is a randomized, double-blind, placebo-controlled, multiple-ascending dose clinical trial evaluating the safety, tolerability, and PK of QRL-101 in up to 60 healthy ...
Pharmabiz5h
SunAct Cancer Institute partners with Smita Memorial Hospital and India’s oncology pioneer Dr Suresh Advani to redefine cancer treatment
Our Bureau, Mumbai Thursday, March 13, 2025, 14:15 Hrs [IST] ...
Pharmabiz5h
Silicon Labs unveils BG29 positioned as future of Bluetooth LE in miniature devices ideal for connected health systems
Silicon Labs unveils BG29 positioned as future of Bluetooth LE in miniature devices ideal for connected health systems: Our Bureau, Bengaluru Thursday, March 13, 2025, 14:30 Hrs [ ...